Conducting Clinical Trials Since 1997
Velocity Clinical Research, Medford was founded by Dr. Edwin Kerwin, a Board Certified Respiratory, Allergy and Clinical Immunology specialist, in 1997 as Clinical Research Institute of Southern Oregon. As an independent dedicated research facility, Velocity Medford has long been a foremost respiratory clinical research center, with a core focus on Allergy, Asthma and COPD clinical studies. Medford is often one of the top enrolling sites nationally for these respiratory indications and has also developed additional expertise in atopic dermatitis and vaccine studies. In addition, selected members of the research team process in-depth knowledge of spirometry assessments.
The site is conveniently located just 10 minutes from the Medford airport with easy access and free parking. Metropolitan Medford has a population of 216,000 with another 300,000 residents in the surrounding counties. A robust database of potential study participants supports other recruiting efforts in this geographic area. With more than 8,500 square-feet of dedicated research space, they can efficiently and effectively conduct multiple concurrent studies. All trials are performed in accordance with ICH and FDA guidelines, and in compliance with GCP.
The Velocity Medford team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine though research. By becoming part of the Velocity Clinical Research organization in 2017, they added new efficiencies and integration to their already comprehensive approaches to conducting clinical trials.